Multiomics-based classifier to decipher immune landscape of uveal melanoma and predict patient outcomes

References

• Afzal, M. Z., Mabaera, R., & Shirai, K. (2018). Metastatic uveal melanoma showing durable response to anti-CTLA-4 and anti-PD-1 combination therapy after experiencing progression on anti-PD-1 therapy alone. Journal for Immunotherapy of Cancer, 6(1), 13. https://doi.org/10.1186/s40425-018-0322-1
   PubMedGoogle Scholar
• Ambrosini, G., Rai, A. J., Carvajal, R. D., & Schwartz, G. K. (2022). Uveal melanoma exosomes induce a prometastatic microenvironment through macrophage migration inhibitory factor. Molecular Cancer Research, 20(4), 661–669. https://doi.org/10.1158/1541-7786.MCR-21-0526
   PubMed Web of Science ®Google Scholar
• Aran, D., Hu, Z., & Butte, A. J. (2017). xCell: Digitally portraying the tissue cellular heterogeneity landscape. Genome Biology, 18(1), 220. https://doi.org/10.1186/s13059-017-1349-1
   PubMed Web of Science ®Google Scholar
• Benhassine, M., Le-Bel, G., & Guérin, S. L. (2022). Contribution of the STAT family of transcription factors to the expression of the serotonin 2B (HTR2B) receptor in human uveal melanoma. International Journal of Molecular Sciences. 23(3), 1564.
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research Network. (2014). Comprehensive molecular characterization of gastric adenocarcinoma. Nature, 513(7517), 202. https://doi.org/10.1038/nature13480
   PubMed Web of Science ®Google Scholar
• Chen, B., Khodadoust, M. S., Liu, C. L., Newman, A. M., & Alizadeh, A. A. (2018). Profiling tumor infiltrating immune cells with CIBERSORT. Methods Molecular Biology, 1711, 243–259.
   Google Scholar
• Chen, Y., Zheng, A., Zhang, Y., Xiao, M., Zhao, Y., Wu, X., Li, M., Du, F., Chen, Y., Chen, M., Li, W., Li, X., Sun, Y., Gu, L., Xiao, Z., & Shen, J. (2022). Dysregulation of B7 family and its association with tumor microenvironment in uveal melanoma. Frontiers in Immunology, 13, 1026076. https://doi.org/10.3389/fimmu.2022.1026076
   PubMed Web of Science ®Google Scholar
• Chi, H., Peng, G., Yang, J., Zhang, J., Song, G., Xie, X., Strohmer, D. F., Lai, G., Zhao, S., Wang, R., Yang, F., & Tian, G. (2022). Machine learning to construct sphingolipid metabolism genes signature to characterize the immune landscape and prognosis of patients with uveal melanoma. Frontiers in Endocrinology, 13, 1056310. https://doi.org/10.3389/fendo.2022.1056310
   PubMed Web of Science ®Google Scholar
• Ding, Y., Yu, J., Chen, X., Wang, S., Tu, Z., Shen, G., Wang, H., Jia, R., Ge, S., Ruan, J., Leong, K. W., & Fan, X. (2021). Dose‐dependent carbon‐dot‐induced ROS promote uveal melanoma cell tumorigenicity via activation of mTOR signaling and glutamine metabolism. Advanced Science, 8(8), 2002404. https://doi.org/10.1002/advs.202002404
   Web of Science ®Google Scholar
• Forsberg, E. M. V., Lindberg, M. F., Jespersen, H., Alsén, S., Bagge, R. O., Donia, M., Svane, I. M., Nilsson, O., Ny, L., Nilsson, L. M., & Nilsson, J. A. (2019). HER2 CAR-T cells eradicate uveal melanoma and T-cell therapy–resistant human melanoma in IL2 transgenic NOD/SCID IL2 receptor knockout mice. Cancer Research, 79(5), 899–904. https://doi.org/10.1158/0008-5472.CAN-18-3158
   PubMed Web of Science ®Google Scholar
• Gu, C., Gu, X., Wang, Y., Yao, Z., & Zhou, C. (2021). Construction and validation of a novel immunosignature for overall survival in uveal melanoma. Frontiers in Cell and Developmental Biology, 9, 710558. https://doi.org/10.3389/fcell.2021.710558
   PubMed Web of Science ®Google Scholar
• Han, A., Purwin, T. J., Bechtel, N., Liao, C., Chua, V., Seifert, E., Sato, T., Schug, Z. T., Speicher, D. W., Harbour, J. W., & Aplin, A. E. (2021). BAP1 mutant uveal melanoma is stratified by metabolic phenotypes with distinct vulnerability to metabolic inhibitors. Oncogene, 40(3), 618–632. https://doi.org/10.1038/s41388-020-01554-y
   PubMed Web of Science ®Google Scholar
• Hou, C., Xiao, L., Ren, X., Tang, F., Guo, B., Zeng, W., Liang, C., & Yan, N. (2020). Mutations of GNAQ, GNA11, SF3B1, EIF1AX, PLCB4 and CYSLTR in Uveal melanoma in Chinese patients. Ophthalmic Research, 63(3), 358–368. https://doi.org/10.1159/000502888
   PubMed Web of Science ®Google Scholar
• Hurdogan, O., De Logu, F., Galli, F., Tuncer, S., Ugolini, F., Simi, S., Portelli, F., Nassini, R., Massi, D., & Buyukbabani, N. (2022). Digital quantification of intratumoral CD8+ T-cells predicts relapse and unfavorable outcome in uveal melanoma. Cancers, 14(23), 5959. https://doi.org/10.3390/cancers14235959
   PubMed Web of Science ®Google Scholar
• Jiang, A., Meng, J., Bao, Y., Wang, A., Gong, W., Gan, X., Wang, J., Bao, Y., Wu, Z., Lu, J., Liu, B., & Wang, L. (2021). Establishment of a prognosis prediction model based on pyroptosis-related signatures associated with the immune microenvironment and molecular heterogeneity in clear cell renal cell carcinoma. Frontiers in Oncology, 11, 755212. https://doi.org/10.3389/fonc.2021.755212
   PubMed Web of Science ®Google Scholar
• Jiang, P., Gu, S., Pan, D., Fu, J., Sahu, A., Hu, X., Li, Z., Traugh, N., Bu, X., Li, B., Liu, J., Freeman, G. J., Brown, M. A., Wucherpfennig, K. W., & Liu, X. S. (2018). Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nature Medicine, 24(10), 1550–1558. https://doi.org/10.1038/s41591-018-0136-1
   PubMed Web of Science ®Google Scholar
• Jiang, Z., Yan, Y., Dong, J., & Duan, L. (2020). PD-1 expression on uveal melanoma induces tumor proliferation and predicts poor patient survival. The International Journal of Biological Markers, 35(3), 50–58. https://doi.org/10.1177/1724600820943610
   PubMed Web of Science ®Google Scholar
• Kamburov, A., Wierling, C., Lehrach, H., & Herwig, R. (2009). ConsensusPathDB—a database for integrating human functional interaction networks. Nucleic Acids Research, 37(Database issue), D623–D628. https://doi.org/10.1093/nar/gkn698
   PubMedGoogle Scholar
• Li, T., Fan, J., Wang, B., Traugh, N., Chen, Q., Liu, J. S., Li, B., & Liu, X. S. (2017). TIMER: A web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Research, 77(21), e108–e110. https://doi.org/10.1158/0008-5472.CAN-17-0307
   PubMed Web of Science ®Google Scholar
• Liberzon, A., Subramanian, A., Pinchback, R., Thorvaldsdóttir, H., Tamayo, P., & Mesirov, J. P. (2011). Molecular signatures database (MSigDB) 3.0. Bioinformatics, 27(12), 1739–1740. https://doi.org/10.1093/bioinformatics/btr260
   PubMed Web of Science ®Google Scholar
• Liu, Y., Li, M., Shi, D., & Zhu, Y. (2019). Higher expression of cation transport regulator-like protein 1 (CHAC1) predicts of poor outcomes in uveal melanoma (UM) patients. International Ophthalmology, 39(12), 2825–2832. https://doi.org/10.1007/s10792-019-01129-1
   PubMed Web of Science ®Google Scholar
• Masclef, L., Ahmed, O., Estavoyer, B., Larrivée, B., Labrecque, N., Nijnik, A., & Affar, E. B. (2021). Roles and mechanisms of BAP1 deubiquitinase in tumor suppression. Cell Death and Differentiation, 28(2), 606–625. https://doi.org/10.1038/s41418-020-00709-4
   PubMed Web of Science ®Google Scholar
• Mayakonda, A., Lin, D.-C., Assenov, Y., Plass, C., & Koeffler, H. P. (2018). Maftools: Efficient and comprehensive analysis of somatic variants in cancer. Genome Research, 28(11), 1747–1756. https://doi.org/10.1101/gr.239244.118
   PubMed Web of Science ®Google Scholar
• Mermel, C. H., Schumacher, S. E., Hill, B., Meyerson, M. L., Beroukhim, R., & Getz, G. (2011). GISTIC2. 0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biology, 12(4), R41. https://doi.org/10.1186/gb-2011-12-4-r41
   PubMed Web of Science ®Google Scholar
• Nathan, P., Hassel, J. C., Rutkowski, P., Baurain, J.-F., Butler, M. O., Schlaak, M., Sullivan, R. J., Ochsenreither, S., Dummer, R., Kirkwood, J. M., Joshua, A. M., Sacco, J. J., Shoushtari, A. N., Orloff, M., Piulats, J. M., Milhem, M., Salama, A. K. S., Curti, B., Demidov, L., … Piperno-Neumann, S, IMCgp100-202 Investigators. (2021). Overall survival benefit with tebentafusp in metastatic uveal melanoma. The New England Journal of Medicine, 385(13), 1196–1206. https://doi.org/10.1056/NEJMoa2103485
   PubMed Web of Science ®Google Scholar
• Pandiani, C., Strub, T., Nottet, N., Cheli, Y., Gambi, G., Bille, K., Husser, C., Dalmasso, M., Béranger, G., Lassalle, S., Magnone, V., Pédeutour, F., Irondelle, M., Maschi, C., Nahon-Estève, S., Martel, A., Caujolle, J.-P., Hofman, P., LeBrigand, K., … Bertolotto, C. (2021). Single-cell RNA sequencing reveals intratumoral heterogeneity in primary uveal melanomas and identifies HES6 as a driver of the metastatic disease. Cell Death and Differentiation, 28(6), 1990–2000. https://doi.org/10.1038/s41418-020-00730-7
   PubMed Web of Science ®Google Scholar
• Pelster, M. S., Gruschkus, S. K., Bassett, R., Gombos, D. S., Shephard, M., Posada, L., Glover, M. S., Simien, R., Diab, A., Hwu, P., Carter, B. W., & Patel, S. P. (2021). Nivolumab and ipilimumab in metastatic uveal melanoma: Results from a single-arm phase II study. Journal of Clinical Oncology, 39(6), 599–607. https://doi.org/10.1200/JCO.20.00605
   PubMed Web of Science ®Google Scholar
• Piaggio, F., Croce, M., Reggiani, F., Monti, P., Bernardi, C., Ambrosio, M., Banelli, B., Dogrusöz, M., Jockers, R., Bordo, D., Puzone, R., Viaggi, S., Coviello, D., Lanza, F. B., Bartolucci, M., Petretto, A., Mosci, C., Gangemi, R., van der Velden, P. A., … Amaro, A. (2022). In uveal melanoma Gα-protein GNA11 mutations convey a shorter disease-specific survival and are more strongly associated with loss of BAP1 and chromosomal alterations than Gα-protein GNAQ mutations. European Journal of Cancer, 170, 27–41. https://doi.org/10.1016/j.ejca.2022.04.013
   PubMed Web of Science ®Google Scholar
• Racle, J., & Gfeller, D. (2020). EPIC: A tool to estimate the proportions of different cell types from bulk gene expression data. Methods in Moledular Biology 2120, 233–248.
   Google Scholar
• Seth, R., Messersmith, H., Kaur, V., Kirkwood, J. M., Kudchadkar, R., McQuade, J. L., Provenzano, A., Swami, U., Weber, J., Alluri, K. C., Agarwala, S., Ascierto, P. A., Atkins, M. B., Davis, N., Ernstoff, M. S., Faries, M. B., Gold, J. S., Guild, S., Gyorki, D. E., … Funchain, P. (2020). Systemic therapy for melanoma: ASCO guideline. Journal of Clinical Oncology, 38(33), 3947–3970. https://doi.org/10.1200/JCO.20.00198
   PubMed Web of Science ®Google Scholar
• Strobel, S. B., Machiraju, D., & Hassel, J. C. (2022). TCR-directed therapy in the treatment of metastatic uveal melanoma. Cancers, 14(5), 1215. https://doi.org/10.3390/cancers14051215
   PubMed Web of Science ®Google Scholar
• Wang, S., Zhang, Q., Yu, C., Cao, Y., Zuo, Y., & Yang, L. (2021). Immune cell infiltration-based signature for prognosis and immunogenomic analysis in breast cancer. Briefings in Bioinformatics, 22(2), 2020–2031. https://doi.org/10.1093/bib/bbaa026
   PubMed Web of Science ®Google Scholar
• Yang, B., Fan, Y., Chen, M., Tang, L., Tang, X., Li, H., Gu, A., Liang, R., & Wu, Y. (2023). Identification and validation of a CCL18-related signature for prediction of overall survival in patients with uveal melanoma. Experimental Eye Research, 230, 109448. https://doi.org/10.1016/j.exer.2023.109448
   PubMed Web of Science ®Google Scholar
• Yang, H., Cai, M.-Y., Rong, H., Ma, L.-R., & Xu, Y.-L. (2021). ZNF667‐AS1, a positively regulating MEGF10, inhibits the progression of uveal melanoma by modulating cellular aggressiveness. Journal of Biochemical and Molecular Toxicology, 35(5), e22732. https://doi.org/10.1002/jbt.22732
   PubMed Web of Science ®Google Scholar
• Yang, L., Wang, S., Zhang, Q., Pan, Y., Lv, Y., Chen, X., Zuo, Y., & Hao, D. (2018). Clinical significance of the immune microenvironment in ovarian cancer patients. Molecular Omics, 14(5), 341–351. https://doi.org/10.1039/c8mo00128f
   PubMed Web of Science ®Google Scholar
• Yu, L., Zhou, D., Zhang, G., Ren, Z., Luo, X., Liu, P., Plouffe, S. W., Meng, Z., Moroishi, T., Li, Y., Zhang, Y., Brown, J. H., Liu, S., & Guan, K.-L. (2022). Co‐occurrence of BAP1 and SF3B1 mutations in uveal melanoma induces cellular senescence. Molecular Oncology, 16(3), 607–629. https://doi.org/10.1002/1878-0261.13128
   PubMed Web of Science ®Google Scholar